3-(N,N-dimethylamino)-1-(3,4,5-trimethoxy-phenyl)propan-1-one hydrochloride | 6336-02-3

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 3-(N,N-dimethylamino)-1-(3,4,5-trimethoxy-phenyl)propan-1-one hydrochloride
• 英文别名: 3-(Dimethylamino)-1-(3,4,5-trimethoxyphenyl)propan-1-one;hydrochloride
• CAS: 6336-02-3
• 化学式: C₁₄H₂₁NO₄*ClH
• 分子量: 303.786
• InChiKey: KJKSUUKLGPVDBM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -2.57
• 重原子数：
  20
• 可旋转键数：
  7
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  49.2
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  3-(N,N-dimethylamino)-1-(3,4,5-trimethoxy-phenyl)propan-1-one hydrochloride 在 盐酸 、 水 作用下， 以 甲醇 、 丙酮 为溶剂， 反应 50.0h， 生成 2-Formyl-6-(3,4,5-trimethoxy-phenyl)-nicotinic acid methyl ester
  参考文献：
  名称：

  Graef, Edgar; Troschuetz, Reinhard, Synthesis, 1999, # 7, p. 1216 - 1222

  摘要：

  DOI：
• 作为产物：
  描述：

  3',4',5'-三甲氧基苯乙酮 、 盐酸二甲胺 在 盐酸 、 paraformaldehyde 作用下， 以 乙醇 、 丙酮 为溶剂， 以65%的产率得到3-(N,N-dimethylamino)-1-(3,4,5-trimethoxy-phenyl)propan-1-one hydrochloride
  参考文献：
  名称：

  Certain 2,5-diaryl tetrahydrofurans and analogs thereof as PAF

  摘要：

  本发明涉及具有以下结构的特定取代四氢呋喃化合物（I）##STR1##其中R.sup.4是含有烷基硫醚，烷基亚砜基或烷基砜基的基团，Y是烷基或取代烷基基团，R.sup.6是烷氧基或取代烷氧基或烷基基团。

  公开号：

  US05010100A1

文献信息

• 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
  申请人：Merck & Co., Inc.

  公开号：US04977146A1

  公开（公告）日：1990-12-11

  The present invention is directed to a specifically substituted tetrahydrofuran of the formula (I) ##STR1## wherein R.sup.4 is an alkylthio, alkylsulfinyl or alkylsulfonyl containing group, Y is an alkyl or substituted alkyl group, R.sup.6 is an alkyl or a substituted alkyl group and the substituents at positions 3, 4 or 5 are acyclic.

  本发明涉及具有以下结构的特定取代四氢呋喃化合物（I）##STR1##其中R.sup.4是含有烷基硫、烷基亚砜或烷基砜基团，Y是烷基或取代烷基团，R.sup.6是烷基或取代烷基团，而3、4或5位的取代基是非环状的。
• Design of Two Alternative Routes for the Synthesis of Naftifine and Analogues as Potential Antifungal Agents
  作者：Rodrigo Abonia、Alexander Garay、Juan Castillo、Braulio Insuasty、Jairo Quiroga、Manuel Nogueras、Justo Cobo、Estefanía Butassi、Susana Zacchino

  DOI：10.3390/molecules23030520

  日期：——

  Two practical and efficient approaches have been implemented as alternative procedures for the synthesis of naftifine and novel diversely substituted analogues 16 and 20 in good to excellent yields, mediated by Mannich-type reactions as the key step of the processes. In these approaches, the γ-aminoalcohols 15 and 19 were obtained as the key intermediates and their subsequent dehydration catalyzed

  已经实施了两种实用且有效的方法作为合成萘替芬和新型多样取代的类似物 16 和 20 的替代程序，收率良好至极好，由曼尼希型反应介导，作为该过程的关键步骤。在这些方法中，γ-氨基醇 15 和 19 作为关键中间体获得，随后它们分别由布朗斯台德酸（如 H2SO4 和 HCl）或路易斯酸（如 AlCl3）催化脱水，生成萘替芬，以及目标烯丙胺 16 和 20抗真菌试验结果表明，中间体 18（在其结构中同时带有 β-氨基酮基和 N-甲基官能团）和产物 20 的活性最强。特别是，结构 18b、18c 和烯丙胺 20c 的 MIC 值最低，在 0.5–7.8 µg/mL 范围内，对抗皮肤癣菌红色毛癣菌和须癣毛癣菌。有趣的是，带有 4-Br 作为苯环取代基的化合物 18b 也显示出对白色念珠菌和新型隐球菌的高活性，MIC80 = 7.8 µg/mL，是杀菌剂而非抑菌剂，相关 MFC 值 = 15.6 µg/
• Development, synthesis, and biological evaluation of (-)-trans-(2S,5S)-2-[3-[(2-oxopropyl)sulfonyl]-4-n-propoxy-5-(3-hydroxypropoxy)-phenyl]-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran, a potent orally active platelet-activating factor (PAF) antagonist and its water-soluble prodrug phosphate ester
  作者：N. N. Girotra、T. Biftu、M. M. Ponpipom、J. J. Acton、A. W. Alberts、T. N. Bach、R. G. Ball、R. L. Bugianesi、J. C. Chabala

  DOI：10.1021/jm00097a005

  日期：1992.9

  (-)-trans-(2S,5S)-2-[3-[(2-Oxopropyl)sulfonyl]-4-n-propoxy-5-(3- hydroxypropoxy)phenyl]-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran (10) is one of the most potent platelet-activating factor (PAF) antagonists in vitro and in vivo developed to date. This diaryltetrahydrofuran derivative evolved from modifications of MK 0287 which has been evaluated in clinical studies for asthma. Two structural modifications

  （-）-反式-（2S，5S）-2- [3-[（2-氧丙基）磺酰基] -4-正丙氧基-5-（3-羟基丙氧基）苯基] -5-（3,4,5 -三甲氧基苯基）四氢呋喃（10）是迄今为止在体外和体内开发的最有效的血小板活化因子（PAF）拮抗剂之一。该二芳基四氢呋喃衍生物是从MK 0287的修饰衍生而来的，该修饰已在哮喘的临床研究中进行了评估。进行了MK 0287的两个结构修改：（1）将3'-[（（羟乙基）磺酰基]基团修饰为β-酮基丙基磺酰基基团；（2）用3-羟丙基醚取代5'-甲基醚。 。化合物10有效且特异性地抑制[3H] -C18-PAF与人血小板膜（Ki 1.85 nM）和PMN膜（Ki 2.89 nM）的结合。体内，10抑制ED50分别为60微克/千克，口服和4微克/千克的静脉注射的雄性大鼠的PAF诱导的血浆外渗和升高的N-乙酰-β-D-氨基葡萄糖苷酶（NAGA）水平，并抑制PAF诱导的支气管
• 2-(3-Aryl-3-oxopropen-1-yl)-9-<i>tert</i>-butyl-paullones: A New Antileishmanial Chemotype
  作者：Christina Reichwald、Orly Shimony、Ute Dunkel、Nina Sacerdoti-Sierra、Charles L. Jaffe、Conrad Kunick

  DOI：10.1021/jm7012166

  日期：2008.2.1

  A screening program directed to find new agents against Leishmania donovani, the parasite causing visceral leishmaniasis, revealed that paullones attenuate the proliferation of axenic amastigotes. Because these structures were not active in a test system involving infected macrophages, a structure optimization campaign was carried out. Concomitant introduction of an unsaturated side chain into the 2-position and a tert-butyl substituent into the 9-position of the parent scaffold led to compounds inhibiting also parasites dwelling in macrophages. By inclusion of the so elaborated scaffold into a chalcone substructure, the toxicity against uninfected host cells was significantly reduced. For the synthesis of this new compound class, a novel modification of the Heck-type palladium-catalyzed C,C-cross coupling strategy was used, employing a ketone Mannich base as precursor for the alkene reactant. The so-prepared compounds exhibited improved antileishmanial activity both on axenic amastigotes (GI(50) < 1 mu M) as well as on parasites in infected macrophages.
• Graef, Edgar; Troschuetz, Reinhard, Synthesis, 1999, # 7, p. 1216 - 1222
  作者：Graef, Edgar、Troschuetz, Reinhard

  DOI：——

  日期：——